Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
281 studies found for:    Open Studies | "Shock"
Show Display Options
Rank Status Study
21 Recruiting Study of Platelet Activation in Septic Shock Patients
Condition: Septic Shock
Interventions: Other: Septic choc group;   Other: Orthopedic surgery group
22 Recruiting Mortality Reduction in Septic Shock by Plasma Adsorption
Condition: Septic Shock
Intervention: Device: High Doses CPFA
23 Recruiting The Effect of Dexmedetomidine on Microcirculation in Septic Shock
Condition: Septic Shock
Intervention: Drug: Dexmedetomidine
24 Recruiting Hemodynamic Effects of Dexmedetomidine in Septic Shock
Condition: Septic Shock
Intervention: Drug: Dexmedetomidine
25 Not yet recruiting TOADS Study: TO Assess Death From Septic Shock.
Condition: Septic Shock
Intervention: Other: epidemiologic study
26 Recruiting Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study
Condition: Septic Shock
Intervention:
27 Not yet recruiting Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
Condition: Septic Shock
Intervention: Biological: blood sampling
28 Recruiting The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
Condition: Septic Shock
Interventions: Drug: Daptomycin;   Other: determination of plasma concentration
29 Not yet recruiting Effects of Administration of Mesenchymal Stem Cells on Organ Failure During the Septic Shock
Condition: Septic Shock
Interventions: Biological: Injection of mesenchymal stem cells;   Biological: Injection of albumin alone
30 Recruiting Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock
Condition: Septic Shock
Interventions: Device: Microdialysis Probe (Muscle microdialysis);   Drug: Dobutamine;   Drug: Levosimendan
31 Recruiting ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
Condition: Cardiogenic Shock
Interventions: Device: Veno-arterial extracorporeal membrane oxygenation (ECMO);   Other: Early conservative therapy according to standard practice
32 Recruiting A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation
Condition: Hypotension and Shock
Interventions: Drug: Isotonic crystalloid solution resuscitation;   Drug: Colloid solution resuscitation
33 Recruiting A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome
Condition: Septic Shock
Intervention:
34 Recruiting Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic Shock
Condition: Septic Shock
Intervention: Device: muscle microdialysis
35 Recruiting Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock
Condition: Cardiogenic Shock
Intervention: Drug: adrenaline
36 Recruiting Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Condition: Septic Shock
Interventions: Drug: selepressin;   Drug: placebo
37 Not yet recruiting Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock
Condition: Shock, Septic
Interventions: Drug: Continuous perfusion of esmolol;   Drug: Continuous perfusion of saline
38 Recruiting Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
Condition: Immunology of Septic Shock
Intervention: Other: Circulating blood (leukocytes)
39 Recruiting Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)
Condition: Septic Shock
Interventions: Drug: OctaplasLG®;   Drug: Ringer-acetat
40 Recruiting Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study
Condition: Toxic Shock Syndrome
Interventions: Drug: Intravenous human immunoglobulin;   Drug: Albumin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.